Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan H Fox

Showing results (61-70 of 178) with videos related to

Pageof 18
Sort By:
Synapse (New York, N.Y.)|January 7, 2015
Pioglitazone may impair L-DOPA anti-parkinsonian efficacy in the MPTP-lesioned macaque: results of a pilot studyPhilippe Huot, Tom H Johnston, Susan H Fox, et al.
Drugs|July 16, 2022
Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's DiseaseDaniel Garbin Di Luca, Nikolai Gil D Reyes, Susan H Fox
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 25, 2017
Automated vision-based analysis of levodopa-induced dyskinesia with deep learningMichael H Li, Tiago A Mestre, Susan H Fox, et al.
Journal of Neuroengineering and Rehabilitation|November 8, 2018
Vision-based assessment of parkinsonism and levodopa-induced dyskinesia with pose estimationMichael H Li, Tiago A Mestre, Susan H Fox, et al.
CNS Drugs|August 14, 2020
Non-Dopaminergic Treatments for Motor Control in Parkinson's Disease: An UpdatePaulina Gonzalez-Latapi, Suvorit Subhas Bhowmick, Gerard Saranza, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 13, 2016
Botulinum Toxin Use in Refractory Pain and Other Symptoms in ParkinsonismVeronica A Bruno, Susan H Fox, Deborah Mancini, et al.
ACS Chemical Neuroscience|May 2, 2017
Serotonergic Approaches in Parkinson's Disease: Translational Perspectives, an UpdatePhilippe Huot, Véronique Sgambato-Faure, Susan H Fox, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 26, 2011
Anatomically selective serotonergic type 1A and serotonergic type 2A therapies for Parkinson's disease: an approach to reducing dyskinesia without exacerbating parkinsonism?Philippe Huot, Susan H Fox, Adrian Newman-Tancredi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2012
A critique of available scales and presentation of the Non-Human Primate Dyskinesia Rating ScaleSusan H Fox, Tom H Johnston, Qin Li, et al.
Clinics in Geriatric Medicine|November 18, 2019
Hallucinations, Delusions and Impulse Control Disorders in Parkinson DiseaseKarlo J Lizarraga, Susan H Fox, Antonio P Strafella, et al.
Pageof 18

Showing results (61-70 of 178) with videos related to

Sort By:
Pageof 18
Synapse (New York, N.Y.)|January 7, 2015
Pioglitazone may impair L-DOPA anti-parkinsonian efficacy in the MPTP-lesioned macaque: results of a pilot studyPhilippe Huot, Tom H Johnston, Susan H Fox, et al.
Drugs|July 16, 2022
Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's DiseaseDaniel Garbin Di Luca, Nikolai Gil D Reyes, Susan H Fox
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 25, 2017
Automated vision-based analysis of levodopa-induced dyskinesia with deep learningMichael H Li, Tiago A Mestre, Susan H Fox, et al.
Journal of Neuroengineering and Rehabilitation|November 8, 2018
Vision-based assessment of parkinsonism and levodopa-induced dyskinesia with pose estimationMichael H Li, Tiago A Mestre, Susan H Fox, et al.
CNS Drugs|August 14, 2020
Non-Dopaminergic Treatments for Motor Control in Parkinson's Disease: An UpdatePaulina Gonzalez-Latapi, Suvorit Subhas Bhowmick, Gerard Saranza, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 13, 2016
Botulinum Toxin Use in Refractory Pain and Other Symptoms in ParkinsonismVeronica A Bruno, Susan H Fox, Deborah Mancini, et al.
ACS Chemical Neuroscience|May 2, 2017
Serotonergic Approaches in Parkinson's Disease: Translational Perspectives, an UpdatePhilippe Huot, Véronique Sgambato-Faure, Susan H Fox, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 26, 2011
Anatomically selective serotonergic type 1A and serotonergic type 2A therapies for Parkinson's disease: an approach to reducing dyskinesia without exacerbating parkinsonism?Philippe Huot, Susan H Fox, Adrian Newman-Tancredi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2012
A critique of available scales and presentation of the Non-Human Primate Dyskinesia Rating ScaleSusan H Fox, Tom H Johnston, Qin Li, et al.
Clinics in Geriatric Medicine|November 18, 2019
Hallucinations, Delusions and Impulse Control Disorders in Parkinson DiseaseKarlo J Lizarraga, Susan H Fox, Antonio P Strafella, et al.
Pageof 18